货号:GS40565
Prafnosbart (also known as Palasobart or DS-6016a) is an investigational humanized monoclonal antibody (IgG1 kappa) designed for the treatment of bone metabolism disorders. Its primary mechanism of action is the specific and high-affinity binding to Activin A receptor type I (ACVR1, also known as ALK2).
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物